Oncology Archives - Page 3 of 3 - MaaT Pharma

Press Releases

December 5, 2024: MaaT Pharma Announces First U.S. Patient Treated at City of Hope Under Single Patient Expanded Access for MaaT013 in Acute Graft-versus-Host Disease

MaaT Pharma Announces First U.S. Patient Treated at City of Hope Under Single Patient Expanded…

MaaT PharmaDecember 5, 2024

Press Releases

November 7, 2024: MaaT Pharma to Present Updates from Early Access Program at the 2024 ASH Annual Meeting Demonstrating Prolonged Long-Term Survival in Patients Receiving MaaT013 in aGvHD

MaaT Pharma to Present Updates from Early Access Program at the 2024 ASH Annual Meeting…

MaaT PharmaNovember 7, 2024

Press Releases

November 5, 2024: MaaT Pharma Provides Third Quarter 2024 Business and Financial Results and Announces Management Changes

MaaT Pharma Provides Third Quarter 2024 Business and Financial Results and Announces Management Changes Completion…

MaaT PharmaNovember 5, 2024

Press Releases

October 15, 2024: MaaT Pharma Completes Recruitment of its ARES Phase 3 Trial for MaaT013 to Treat Acute Graft-versus-Host Disease

MaaT Pharma Completes Recruitment of its ARES Phase 3 Trial for MaaT013 to Treat Acute…

MaaT PharmaOctober 15, 2024

© 2025 MaaT Pharma. MaaT Pharma’s mission is to restore microbiome function to treat life-threatening diseases

MaaT Pharma dans les médias MaaT Pharma in the News Devenez membre du club Become a member of the club